Altor Bioscience Corporation

Miramar, FL 33025

SBIR Award Summary

Total Number of Awards 36
Total Value of Awards $18.6MM
First Award Date 01/15/98
Most Recent Award Date 08/08/17

Key Personnel

Last Name Name Awards Contact
Weidanz Jon Weidanz 1
Wong Hing C. Wong 26
Rhode Peter R Rhode 5
Negrouk Valentin Negrouk 1
Egan Jack Owen Egan 3

36 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-CA-16-008
Budget: 08/08/17 - 07/31/18

Project Summary: Bladder cancer is the fifth most common cancer in the U.S. Up to 80% of patients initially present with non-muscle invasive bladder cancer (NMIBC) confined to the mucosa of the bladder. These patients are treated by tumor resection followed by intravesical chemotherapy or Bacillus Calmette-Guérin (BCG) therapy. Despite treatment...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 09/30/16 - 09/29/17

? DESCRIPTION (provided by applicant): Non-Hodgkin lymphoma (NHL) is the most commonly diagnosed hematologic malignancy in the U.S. with over 70,000 new cases and about 19,000 deaths due to NHL expected in 2015. Over one third of all cases are slow-growing or indolent NHL (iNHL) which affect older adults and typically present as advanced dise...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 09/30/15 - 09/29/16

DESCRIPTION (provided by applicant): Non-Hodgkin lymphoma (NHL) is the most commonly diagnosed hematologic malignancy in the U.S. with over 70,000 new cases and about 19,000 deaths due to NHL expected in 2015. Over one third of all cases are slow-growing or indolent NHL (iNHL) which affect older adults and typically present as advanced disease. ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 08/01/15 - 07/31/16

DESCRIPTION (provided by applicant): Bladder cancer is the fifth most common cancer in the United States. Over 70 - 80% of patients initially present with non-muscle invasive bladder cancer (NMIBC) confined to the mucosa of the bladder. These patients are treated by tumor resection followed by intravesical chemotherapy or Bacillus Calmette-Gu?r...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 06/01/15 - 05/31/16

DESCRIPTION (provided by applicant): Multiple myeloma (MM) is the second most commonly diagnosed hematologic malignancy with an estimated 22,350 newly diagnosed cases and 10,710 deaths due to MM in the United States in 2013. MM, typically a disease of the elderly, is a malignancy of clonal plasma cells in the bone marrow (BM) characterized by t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 08/15/14 - 07/31/15

DESCRIPTION (provided by applicant): Bladder cancer is the fifth most common cancer in the United States. Over 70 - 80% of patients initially present with non-muscle invasive bladder cancer (NMIBC) confined to the mucosa of the bladder. These patients are treated by tumor resection followed by intravesical chemotherapy or Bacillus Calmette-Guri...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 06/17/14 - 05/31/15

DESCRIPTION (provided by applicant): Multiple myeloma (MM) is the second most commonly diagnosed hematologic malignancy with an estimated 22,350 newly diagnosed cases and 10,710 deaths due to MM in the United States in 2013. MM, typically a disease of the elderly, is a malignancy of clonal plasma cells in the bone marrow (BM) characterized by t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 06/01/13 - 05/31/14

DESCRIPTION (provided by applicant): The pathogenesis of ALI/ARDS involves both procoagulant and inflammatory mechanisms. Extravascular fibrin deposition in the lung is a characteristic pathologic feature of ALI/ARDS and intra-alveolar thrombi develop in the lungs of patients with ALI/ARDS. Tissue factor (TF), the trigger protein for activation...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 09/27/12 - 08/31/13

DESCRIPTION (provided by applicant): Non-Hodgkin lymphoma (NHL) represents a significant clinical challenge in cancer management. Approximately 70,000 new cases of NHL are diagnosed annually in the U.S. and NHL ranks fifth in cancer incidence and mortality. The majority of NHL cases are of B-cell origin and more than 90% express the leukocyte an...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-11-096
Budget: 07/11/12 - 06/30/13

DESCRIPTION (provided by applicant): Multiple myeloma (MM) is the second most commonly diagnosed hematologic malignancy with an estimated 20,520 newly diagnosed cases and 10,610 deaths due to MM in the United States in 2011. MM is a disease of the elderly with a median age at diagnosis of 70 years and 37% of patients older than 75 years. The nu...

Load More